[1] YANG M Q, VAN VELZEN R, BAKKER F T, et al.Molecular phylogenetics and character evolution of Cannabaceae[J]. Taxon, 2013, 62(3): 473-485.
[2] MCPARTLAND J M.Cannabis systematics at the levels of family, genus, and species[J]. Cannabis and Cannabinoid Research, 2018, 3(1): 203-212.
[3] II A.An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG II[J]. Botanical Journal of the Linnean Society, 2003, 141(4): 399-436.
[4] LUO X Z, REITER M A, D'ESPAUX L, et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast[J]. Nature, 2019, 567(7746): 123-126.
[5] LI H L.The origin and use of cannabis in Eastern Asia linguistic-cultural implications[J]. Economic Botany, 1974, 28(3): 293-301.
[6] 刘飞虎, 杨明. 工业大麻的基础与应用[M]. 北京: 科学出版社, 2015.
[7] TAURA F, SIRIKANTARAMAS S, SHOYAMA Y, et al.Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes[J]. Chemistry & Biodiversity, 2007, 4(8): 1649-1663.
[8] HILLIG K W.Genetic evidence for speciation in cannabis (Cannabaceae)[J]. Genetic Resources and Crop Evolution, 2005, 52(2): 161-180.
[9] LUBMAN D I, CHEETHAM A, YÜCEL M. Cannabis and adolescent brain development[J]. Pharmacology & Therapeutics, 2015, 148: 1-16.
[10] MAA E, FIGI P.The case for medical marijuana in epilepsy[J]. Epilepsia, 2014, 55(6): 783-786.
[11] DEVINSKY O, MARSH E, FRIEDMAN D, et al.Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial[J]. The Lancet Neurology, 2016, 15(3): 270-278.
[12] ZUARDI A W, ANTUNES RODRIGUES J, CUNHA J M.Effects of cannabidiol in animal models predictive of antipsychotic activity[J]. Psychopharmacology, 1991, 104(2): 260-264.
[13] LEWEKE F, SCHNEIDER U, RADWAN M, et al.Different effects of nabilone and cannabidiol on binocular depth inversion in man[J]. Pharmacology Biochemistry and Behavior, 2000, 66(1): 175-181.
[14] BOYCHUK D G, GODDARD G, MAURO G, et al.The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review[J]. Journal of Oral & Facial Pain and Headache, 2015, 29(1): 7-14.
[15] BLESSING E M, STEENKAMP M M, MANZANARES J, et al.Cannabidiol as a potential treatment for anxiety disorders[J]. Neurotherapeutics, 2015, 12(4): 825-836.
[16] CHAGAS M H N, ECKELI A L, ZUARDI A W, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series[J]. Journal of Clinical Pharmacy and Therapeutics, 2014, 39(5): 564-566.
[17] BURSTEIN S.Cannabidiol (CBD) and its analogs: a review of their effects on inflammation[J]. Bioorganic & Medicinal Chemistry, 2015, 23(7): 1377-1385.
[18] NOONAN D.Marijuana’s medical future[J]. Scientific American, 2015, 312(2): 32-34.
[19] BEN AMAR M.Cannabinoids in medicine: a review of their therapeutic potential[J]. Journal of Ethnopharmacology, 2006, 105(1/2): 1-25.
[20] 李秋实, 孟莹, 陈士林. 药用大麻种质资源分类与研究策略[J]. 中国中药杂志, 2019, 44(20): 4309-4316.
[21] SIRIKANTARAMAS S, TAURA F, MORIMOTO S, et al.Recent advances in cannabis sativa research: biosynthetic studies and its potential in biotechnology[J]. Current Pharmaceutical Biotechnology, 2007, 8(4): 237-243.
[22] 陈士林. 本草基因组学[M]. 北京: 科学出版社, 2017.
[23] 徐炜, 杨淑君, 朱开才, 等. 兰州新区发展工业大麻产业可行性研究[J]. 发展, 2019(7): 46-47.
[24] 李长年. 麻类作物:上篇[M].北京:农业出版社,1962.
[25] 李宗道. 麻作的理论与技术[M].上海:上海科学技术出版社,1980.
[26] 孙福来, 王绪芬, 张秀慧. 高效环保型经济作物工业大麻及栽培技术[J]. 中国种业, 2004(10): 49-50. |
